Matthew Murphy

Matthew Murphy is a Senior Principal Scientist in Viral Vector Process Development at Regeneron, where they focus on advancing biopharmaceutical technologies. They have over 15 years of combined industrial and laboratory experience, including roles at companies such as bluebird bio and GlaxoSmithKline, where they managed substantial budgets and coordinated multidisciplinary teams. Matthew holds a Master of Engineering in Project Management from the University of Maryland College Park and a Bachelor of Science in Biomedical Engineering from Case Western Reserve University. They have demonstrated expertise in bioprocessing, automation engineering, and regulatory strategies throughout their career.